{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:29:09Z","timestamp":1740144549946,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13019-019-0875-1","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T13:03:04Z","timestamp":1552914184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Influence of Mitroflow bioprosthesis structural valve deterioration on cardiac morbidity"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3583-4366","authenticated-orcid":false,"given":"Farhad","family":"Waziri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zarmiga","family":"Karunanithi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian Bridal","family":"L\u00f8gstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibeke","family":"Hjortdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Hostrup","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen Hvitfeldt","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"875_CR1","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jtcvs.2008.05.022","volume":"136","author":"CA Yankah","year":"2008","unstructured":"Yankah CA, Pasic M, Musci M, Stein J, Detschades C, Siniawski H, et al. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. J Thorac Cardiovasc Surg. 2008;136:688\u201396. \n                    https:\/\/doi.org\/10.1016\/j.jtcvs.2008.05.022\n                    \n                  .","journal-title":"J Thorac Cardiovasc Surg"},{"key":"875_CR2","first-page":"197","volume":"15","author":"J Sjogren","year":"2006","unstructured":"Sjogren J, Gudbjartsson T, Thulin LI. Long-term outcome of the MitroFlow pericardial bioprosthesis in the elderly after aortic valve replacement. J Heart Valve Dis. 2006;15:197\u2013202.","journal-title":"J Heart Valve Dis"},{"key":"875_CR3","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.athoracsur.2014.10.070","volume":"99","author":"DR Johnston","year":"2015","unstructured":"Johnston DR, Soltesz EG, Vakil N, Rajeswaran J, Roselli EE, Sabik JF, et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg. 2015;99:1239\u201347. \n                    https:\/\/doi.org\/10.1016\/j.athoracsur.2014.10.070\n                    \n                  .","journal-title":"Ann Thorac Surg"},{"key":"875_CR4","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.athoracsur.2005.04.053","volume":"80","author":"K Minami","year":"2005","unstructured":"Minami K, Zittermann A, Schulte-Eistrup S, Koertke H, K\u00f6rfer R. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients. Ann Thorac Surg. 2005;80:1699\u2013705. \n                    https:\/\/doi.org\/10.1016\/j.athoracsur.2005.04.053\n                    \n                  .","journal-title":"Ann Thorac Surg"},{"key":"875_CR5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ejcts.2009.05.020","volume":"36","author":"WRE Jamieson","year":"2009","unstructured":"Jamieson WRE, Koerfer R, Yankah CA, Zittermann A, Hayden RI, Ling H, et al. Mitroflow aortic pericardial bioprosthesis - clinical performance. Eur J Cardio-Thoracic Surg. 2009;36:818\u201324. \n                    https:\/\/doi.org\/10.1016\/j.ejcts.2009.05.020\n                    \n                  .","journal-title":"Eur J Cardio-Thoracic Surg"},{"key":"875_CR6","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/ejcts\/ezv432","volume":"49","author":"PH Nielsen","year":"2016","unstructured":"Nielsen PH, Hjortdal V, Modrau IS, Jensen H, Kimose HH, Terp K, et al. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients. Eur J Cardio-Thoracic Surg. 2016;49:1705\u201310. \n                    https:\/\/doi.org\/10.1093\/ejcts\/ezv432\n                    \n                  .","journal-title":"Eur J Cardio-Thoracic Surg"},{"key":"875_CR7","doi-asserted-by":"publisher","unstructured":"Alvarez JR, Sierra J, Vega M, Adrio B, Martinez-Comendador J, Gude F, et al. Early calcification of the aortic Mitroflow pericardial bioprosthesis in the elderly. Interact Cardiovasc Thorac Surg. 2009;9:842\u20136. \n                    https:\/\/doi.org\/10.1510\/icvts.2009.204958\n                    \n                  .","DOI":"10.1510\/icvts.2009.204958"},{"key":"875_CR8","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.114.010400","volume":"130","author":"T S\u00e9nage","year":"2014","unstructured":"S\u00e9nage T, Le Tourneau T, Foucher Y, Pattier S, Cueff C, Michel M, et al. Early structural valve deterioration of mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients. Circulation. 2014;130:2012\u201320. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.010400\n                    \n                  .","journal-title":"Circulation"},{"key":"875_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2147\/CLEP.S10190","volume":"2","author":"M Schmidt","year":"2010","unstructured":"Schmidt M, Maeng M, Jakobsen CJ, Madsen M, Thuesen L, Hostrup Nielsen P, et al. Existing data sources for clinical epidemiology: the western Denmark heart registry. Clin Epidemiol. 2010;2:137\u201344. \n                    https:\/\/doi.org\/10.2147\/CLEP.S10190\n                    \n                  .","journal-title":"Clin Epidemiol"},{"key":"875_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39:22\u20135. \n                    https:\/\/doi.org\/10.1177\/1403494810387965\n                    \n                  .","journal-title":"Scand J Public Health"},{"key":"875_CR11","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","volume":"285","author":"PA McKee","year":"1971","unstructured":"McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441\u20136. \n                    https:\/\/doi.org\/10.1056\/NEJM197112232852601\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"875_CR12","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1053\/euhj.2000.2533","volume":"22","author":"A Mosterd","year":"2001","unstructured":"Mosterd A, Cost B, Hoes AW, De Bruijne MC, Deckers JW, Hofman A, et al. The prognosis of heart failure in the general population: the Rotterdam study. Eur Heart J. 2001;22:1318\u201327. \n                    https:\/\/doi.org\/10.1053\/euhj.2000.2533\n                    \n                  .","journal-title":"Eur Heart J"},{"key":"875_CR13","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM198706043162301.","volume":"316","author":"Group CTS","year":"1987","unstructured":"Group CTS. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987;316:1429\u201335. \n                    https:\/\/doi.org\/10.1056\/NEJM198706043162301.","journal-title":"N Engl J Med"},{"key":"875_CR14","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF Study Group","year":"1999","unstructured":"MERIT-HF Study Group. Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet. 1999;353:2001\u20137. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(99)04440-2\n                    \n                  .","journal-title":"Lancet"},{"key":"875_CR15","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","volume":"273","author":"R Garg","year":"1995","unstructured":"Garg R, Yusuf S, Bussmann WD, Sleight P, Uprichard A, Massie B, et al. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA J Am Med Assoc. 1995;273:1450\u20136. \n                    https:\/\/doi.org\/10.1001\/jama.1995.03520420066040\n                    \n                  .","journal-title":"JAMA J Am Med Assoc"},{"key":"875_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","author":"L Aaron","year":"1991","unstructured":"Aaron L. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293\u2013302. \n                    https:\/\/doi.org\/10.1056\/NEJM199108013250501\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"875_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moy\u00e9 LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669\u201377. \n                    https:\/\/doi.org\/10.1056\/NEJM199209033271001\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"875_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/jocs.12726","volume":"31","author":"VX Mosquera","year":"2016","unstructured":"Mosquera VX, Bouzas-Mosquera A, Velasco-Garc\u00eda C, Mu\u00f1iz J, Est\u00e9vez-Cid F, Portela-Torron F, et al. Long-term outcomes and durability of the Mitroflow aortic bioprosthesis. J Card Surg. 2016;31:264\u201373. \n                    https:\/\/doi.org\/10.1111\/jocs.12726\n                    \n                  .","journal-title":"J Card Surg"},{"key":"875_CR19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.athoracsur.2015.03.002","volume":"100","author":"M Anantha Narayanan","year":"2015","unstructured":"Anantha Narayanan M, Suri RM, Ugur M, Greason KL, Stulak JM, Dearani JA, et al. Predictors of survival and modes of failure after Mitroflow aortic valve replacement in 1,003 adults. Ann Thorac Surg. 2015;100:560\u20137. \n                    https:\/\/doi.org\/10.1016\/j.athoracsur.2015.03.002\n                    \n                  .","journal-title":"Ann Thorac Surg"},{"key":"875_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/ejcts\/ezx161","volume":"52","author":"F Ius","year":"2017","unstructured":"Ius F, Schulz J, Roumieh M, Fleissner F, Ismail I, Tudorache I, et al. Long-term results of the Mitroflow aortic pericardial bioprosthesis in over 800 patients: limited durability and mechanisms of dysfunction. Eur J Cardio-Thoracic Surg. 2017;52:264\u201371. \n                    https:\/\/doi.org\/10.1093\/ejcts\/ezx161\n                    \n                  .","journal-title":"Eur J Cardio-Thoracic Surg"},{"key":"875_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.athoracsur.2014.07.031","volume":"99","author":"A Luk","year":"2015","unstructured":"Luk A, Cusimano RJ, Butany J. Pathologic evaluation of 28 mitroflow pericardial valves: a 12-year experience. Ann Thorac Surg. 2015;99:48\u201354. \n                    https:\/\/doi.org\/10.1016\/j.athoracsur.2014.07.031\n                    \n                  .","journal-title":"Ann Thorac Surg"},{"key":"875_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jama.2014.7246.4","volume":"8","author":"JE Nielsen-Kudsk","year":"2015","unstructured":"Nielsen-Kudsk JE, Christiansen EH, Jensen KT, Krusell LR, Tang M, Terp K, et al. Images and case reports in interventional cardiology fracturing the ring of small Mitroflow bioprostheses. Circ Cardiovasc Interv. 2015;8:1\u20135. \n                    https:\/\/doi.org\/10.1001\/jama.2014.7246.4\n                    \n                  .","journal-title":"Circ Cardiovasc Interv"},{"key":"875_CR23","doi-asserted-by":"publisher","unstructured":"Chhatriwalla AK, Allen KB, Saxon JT, Cohen DJ, Aggarwal S, Hart AJ, et al. Bioprosthetic valve fracture improves the hemodynamic results of valve-in-valve Transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2017;10. \n                    https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.005216\n                    \n                  .","DOI":"10.1161\/CIRCINTERVENTIONS.117.005216"},{"key":"875_CR24","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.4244\/EIJ-D-17-00244","volume":"13","author":"JE Nielsen-Kudsk","year":"2017","unstructured":"Nielsen-Kudsk JE, Andersen A, Therkelsen CJ, Christensen EH, Jensen KT, Krusell LR, et al. High-pressure balloon fracturing of small dysfunctional Mitroflow bioprostheses facilitates transcatheter aortic valve-in-valve implantation. EuroIntervention. 2017;13:e1020\u20135. \n                    https:\/\/doi.org\/10.4244\/EIJ-D-17-00244\n                    \n                  .","journal-title":"EuroIntervention"},{"key":"875_CR25","doi-asserted-by":"publisher","first-page":"e1026","DOI":"10.4244\/EIJ-D-17-00245","volume":"13","author":"P Johansen","year":"2017","unstructured":"Johansen P, Engholt H, Tang M, Nybo R, Rasmussen P, Nielsen-Kudsk JE. Fracturing mechanics before valve-in-valve therapy of small aortic bioprosthetic heart valves. EuroIntervention. 2017;13:e1026\u201331. \n                    https:\/\/doi.org\/10.4244\/EIJ-D-17-00245\n                    \n                  .","journal-title":"EuroIntervention"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-019-0875-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13019-019-0875-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-019-0875-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:27:35Z","timestamp":1584404855000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-019-0875-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["875"],"URL":"https:\/\/doi.org\/10.1186\/s13019-019-0875-1","relation":{},"ISSN":["1749-8090"],"issn-type":[{"type":"electronic","value":"1749-8090"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"30 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Danish National Health Board (ref no: 1\u201316\u201302-527-16) and the Danish Data protection Agency (ref. no: 2012\u201358-006).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"62"}}